{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:02:28Z","timestamp":1789779748009,"version":"4.0.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,10,26]],"date-time":"2016-10-26T00:00:00Z","timestamp":1477440000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,10,26]],"date-time":"2016-10-26T00:00:00Z","timestamp":1477440000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["6T32 DK007 110-41"],"award-info":[{"award-number":["6T32 DK007 110-41"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00467-016-3459-5","type":"journal-article","created":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T22:37:08Z","timestamp":1477435028000},"page":"965-974","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Steroid-resistant nephrotic syndrome: a persistent challenge for pediatric nephrology"],"prefix":"10.1007","volume":"32","author":[{"given":"Samriti","family":"Dogra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Kaskel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,26]]},"reference":[{"key":"3459_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1097-2765(00)80057-X","volume":"1","author":"M Kestila","year":"1998","unstructured":"Kestila M, Lenkkeri U, Mannikko M, Lamerdin J, McCready P, Putaala H, Ruotsalainen V, Morita T, Nissinen M, Herva R, Kashtan CE, Peltonen L, Holmberg C, Olsen A, Tryggvason K (1998) Positionally cloned gene for a novel glomerular protein\u2014nephrin\u2014is mutated in congenital nephrotic syndrome. Mol Cell 1:575\u2013582","journal-title":"Mol Cell"},{"key":"3459_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/74166","volume":"24","author":"N Boute","year":"2000","unstructured":"Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, Dahan K, Gubler MC, Niaudet P, Antignac C (2000) NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 24:349\u2013354","journal-title":"Nat Genet"},{"key":"3459_CR3","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/ng1918","volume":"38","author":"B Hinkes","year":"2006","unstructured":"Hinkes B, Wiggins RC, Gbadegesin R, Vlangos CN, Seelow D, Nurnberg G, Garg P, Verma R, Chaib H, Hoskins BE, Ashraf S, Becker C, Hennies HC, Goyal M, Wharram BL, Schachter AD, Mudumana S, Drummond I, Kerjaschki D, Waldherr R, Dietrich A, Ozaltin F, Bakkaloglu A, Cleper R, Basel-Vanagaite L, Pohl M, Griebel M, Tsygin AN, Soylu A, Muller D, Sorli CS, Bunney TD, Katan M, Liu J, Attanasio M, O'Toole JF, Hasselbacher K, Mucha B, Otto EA, Airik R, Kispert A, Kelley GG, Smrcka AV, Gudermann T, Holzman LB, Nurnberg P, Hildebrandt F (2006) Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat Genet 38:1397\u20131405","journal-title":"Nat Genet"},{"key":"3459_CR4","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1126\/science.286.5438.312","volume":"286","author":"NY Shih","year":"1999","unstructured":"Shih NY, Li J, Karpitskii V, Nguyen A, Dustin ML, Kanagawa O, Miner JH, Shaw AS (1999) Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science 286:312\u2013315","journal-title":"Science"},{"key":"3459_CR5","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1126\/science.1106215","volume":"308","author":"MP Winn","year":"2005","unstructured":"Winn MP, Conlon PJ, Lynn KL, Farrington MK, Creazzo T, Hawkins AF, Daskalakis N, Kwan SY, Ebersviller S, Burchette JL, Pericak-Vance MA, Howell DN, Vance JM, Rosenberg PB (2005) A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 308:1801\u20131804","journal-title":"Science"},{"key":"3459_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/73456","volume":"24","author":"JM Kaplan","year":"2000","unstructured":"Kaplan JM, Kim SH, North KN, Rennke H, Correia LA, Tong HQ, Mathis BJ, Rodriguez-Perez JC, Allen PG, Beggs AH, Pollak MR (2000) Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 24:251\u2013256","journal-title":"Nat Genet"},{"key":"3459_CR7","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/0092-8674(91)90194-4","volume":"67","author":"J Pelletier","year":"1991","unstructured":"Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L, Fine RN, Silverman BL, Haber DA, Housman D (1991) Germline mutations in the Wilms\u2019 tumor suppressor gene are associated with abnormal urogenital development in Denys\u2013Drash syndrome. Cell 67:437\u2013447","journal-title":"Cell"},{"key":"3459_CR8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/ng1297-467","volume":"17","author":"S Barbaux","year":"1997","unstructured":"Barbaux S, Niaudet P, Gubler MC, Grunfeld JP, Jaubert F, Kuttenn F, Fekete CN, Souleyreau-Therville N, Thibaud E, Fellous M, McElreavey K (1997) Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet 17:467\u2013470","journal-title":"Nat Genet"},{"key":"3459_CR9","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1093\/hmg\/ddh284","volume":"13","author":"M Zenker","year":"2004","unstructured":"Zenker M, Aigner T, Wendler O, Tralau T, Muntefering H, Fenski R, Pitz S, Schumacher V, Royer-Pokora B, Wuhl E, Cochat P, Bouvier R, Kraus C, Mark K, Madlon H, Dotsch J, Rascher W, Maruniak-Chudek I, Lennert T, Neumann LM, Reis A (2004) Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities. Hum Mol Genet 13:2625\u20132632","journal-title":"Hum Mol Genet"},{"key":"3459_CR10","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/ki.2011.472","volume":"81","author":"L Wang","year":"2012","unstructured":"Wang L, Ellis MJ, Gomez JA, Eisner W, Fennell W, Howell DN, Ruiz P, Fields TA, Spurney RF (2012) Mechanisms of the proteinuria induced by Rho GTPases. Kidney Int 81:1075\u20131085","journal-title":"Kidney Int"},{"issue":"8","key":"3459_CR11","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1172\/JCI69134","volume":"123","author":"HY Gee","year":"2013","unstructured":"Gee HY, Saisawat P, Ashraf S, Hurd TW, Vega-Warner V, Fang H, Beck BB, Gribouval O, Zhou W, Diaz KA, Natarajan S, Wiggins RC, Lovric S, Chernin G, Schoeb DS, Ovunc B, Frishberg Y, Soliman NA, Fathy HM, Goebel H, Hoefele J, Weber LT, Innis JW, Faul C, Han Z, Washburn J, Antignac C, Levy S, Otto EA, Hildebrandt F (2013) ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling. J Clin Invest 123(8):3243\u20133253","journal-title":"J Clin Invest"},{"key":"3459_CR12","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1681\/ASN.V1291994","volume":"12","author":"JR Hoyer","year":"2001","unstructured":"Hoyer JR, Vernier RL, Najarian JS, Raij L, Simmons RL, Michael AF (2001) Recurrence of idiopathic nephrotic syndrome after renal transplantation. J Am Soc Nephrol 12:1994\u20132002","journal-title":"J Am Soc Nephrol"},{"key":"3459_CR13","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/S0272-6386(12)80381-7","volume":"23","author":"ML Artero","year":"1994","unstructured":"Artero ML, Sharma R, Savin VJ, Vincenti F (1994) Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 23:574\u2013581","journal-title":"Am J Kidney Dis"},{"key":"3459_CR14","first-page":"32","volume":"22","author":"SW Zimmerman","year":"1984","unstructured":"Zimmerman SW (1984) Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation. Clin Nephrol 22:32\u201338","journal-title":"Clin Nephrol"},{"key":"3459_CR15","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1056\/NEJM199604043341402","volume":"334","author":"VJ Savin","year":"1996","unstructured":"Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, Ellis E, Lovell H, Warady B, Gunwar S, Chonko AM, Artero M, Vincenti F (1996) Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 334:878\u2013888","journal-title":"N Engl J Med"},{"issue":"8","key":"3459_CR16","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/nm.2411","volume":"17","author":"C Wei","year":"2011","unstructured":"Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, Maiguel D, Karumanchi SA, Yap HK, Saleem M, Zhang Q, Nikolic B, Chaudhuri A, Daftarian P, Salido E, Torres A, Salifu M, Sarwal MM, Schaefer F, Morath C, Schwenger V, Zeier M, Gupta V, Roth D, Rastaldi MP, Burke G, Ruiz P, Reiser J (2011) Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 17(8):952\u2013960","journal-title":"Nat Med"},{"key":"3459_CR17","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/nrm977","volume":"3","author":"F Blasi","year":"2002","unstructured":"Blasi F, Carmeliet P (2002) uPAR: A versatile signaling orchestrator. Nat Rev Mol Cell Biol 3:932\u2013943","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3459_CR18","first-page":"1843","volume":"58","author":"CF Sier","year":"1998","unstructured":"Sier CF, Stephens R, Bizik J, Mariani A, Bassan M, Pedersen N, Frigerio L, Ferrari A, Dan\u00f8 K, Br\u00fcnner N, Blasi F (1998) The level of urokinase-type plasminogen activator receptor is increased in the serum of ovarian cancer patients. Cancer Res 58:1843\u20131849","journal-title":"Cancer Res"},{"key":"3459_CR19","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1182\/blood.V96.13.4091","volume":"96","author":"N Sidenius","year":"2000","unstructured":"Sidenius N, Sier CF, Ullum H, Pedersen BK, Lepri AC, Blasi F, Eugen-Olsen J l (2000) Serum levels of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection. Blood 96:4091\u20134095","journal-title":"Blood"},{"key":"3459_CR20","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/ki.2013.505","volume":"85","author":"B Meijers","year":"2014","unstructured":"Meijers B, Maas R, Sprangers B, Claes K, Poesen R, Bammens B, Naesens M, Deegens J, Dietrich R, Storr M, Wetzels J, Evenepoel P, Kuypers D (2014) The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis. Kidney Int 85:636\u2013640","journal-title":"Kidney Int"},{"key":"3459_CR21","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.2215\/CJN.07680712","volume":"8","author":"ME Bock","year":"2013","unstructured":"Bock ME, Price HE, Gallon L, Langman CB (2013) Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report. Clin J Am Soc Nephrol 8:1304\u20131311","journal-title":"Clin J Am Soc Nephrol"},{"key":"3459_CR22","doi-asserted-by":"publisher","first-page":"e907","DOI":"10.1542\/peds.2006-2164","volume":"119","author":"BG Hinkes","year":"2007","unstructured":"Hinkes BG, Mucha B, Vlangos CN, Gbadegesin R, Liu J, Hasselbacher K, Hangan D, Ozaltin F, Zenker M, Hildebrandt F (2007) Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics 119:e907\u2013e919","journal-title":"Pediatrics"},{"key":"3459_CR23","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/ki.2013.93","volume":"84","author":"S Beata","year":"2013","unstructured":"Beata S, Lipska BS, Iatropoulos P, Maranta R, Caridi G, Ozaltin F, Anarat A, Balat A, Gellermann J, Trautmann A, Erdogan O, Saeed B, Emre S, Bogdanovic R, Azocar M, Balasz-Chmielewska I, Benetti E, Caliskan S, Mir S, Melk A, Ertan P, Baskin E, Jardim H, Davitaia T, Wasilewska A, Drozdz D, Szczepanska M, Jankauskiene A, Higuita L, Ardissino G, Ozkaya O, Kuzma-Mroczkowska E, Soylemezoglu O, Ranchin B, Medynska A, Tkaczyk M, Peco-Antic A, Akil I, Jarmolinski T, Firszt-Adamczyk A, Dusek J, Simonetti GD, Gok F, Gheissari A, Emma F, Krmar RT, Fischbach M, Printza N, Simkova E, Mele C, Ghiggeri GM, Schaefer F, the PodoNet Consortium (2013) Genetic screening in adolescents with steroid resistant nephrotic syndrome. Kidney Int 84:206\u2013213","journal-title":"Kidney Int"},{"key":"3459_CR24","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2215\/CJN.07200712","volume":"8","author":"HJ McCarthy","year":"2013","unstructured":"McCarthy HJ, Bierzynska A, Wherlock M, Ognjanovic M, Kerecuk L, Hegde S, Feather S, Gilbert RD, Krischock L, Jones C, Sinha MD, Webb N, Christian M, Williams MM, Marks S, Koziell A, Welsh GI, Saleem MA (2013) Simultaneous sequencing of 24 genes associated with steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 8:637\u2013648","journal-title":"Clin J Am Soc Nephrol"},{"key":"3459_CR25","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.2215\/CJN.05260610","volume":"6","author":"S Sant\u00edn","year":"2011","unstructured":"Sant\u00edn S, Bullich G, Tazon-Vega B, Garc\u00eda-Maset R, Gimenez I, Silva I, Ru\u00edz P, Ballar\u00edn J, Torra R, Ars E (2011) Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 6:1139\u20131148","journal-title":"Clin J Am Soc Nephrol"},{"key":"3459_CR26","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s00467-010-1495-0","volume":"25","author":"G Benoit","year":"2010","unstructured":"Benoit G, Machuca E, Antignac C (2010) Hereditary nephrotic syndrome: a systematic approach for genetic testing and a review of associated podocyte gene mutations. Pediatr Nephrol 25:1621\u20131632","journal-title":"Pediatr Nephrol"},{"key":"3459_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nrneph.2012.286","volume":"9","author":"RA Gbadegesin","year":"2013","unstructured":"Gbadegesin RA, Winn MP, Smoyer WE (2013) Genetic testing in nephrotic syndrome\u2014challenges and opportunities. Nat Rev Nephrol 9:179\u2013184","journal-title":"Nat Rev Nephrol"},{"key":"3459_CR28","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s00467-010-1468-3","volume":"25","author":"J Gellermann","year":"2010","unstructured":"Gellermann J, Constantinos J, Stefanidis CJ, Mitsioni A, Querfeld U (2010) Successful treatment of steroid-resistant nephrotic syndrome associated with WT1 mutations. Pediatr Nephrol 25:1285\u20131289","journal-title":"Pediatr Nephrol"},{"issue":"12","key":"3459_CR29","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/ng1918","volume":"38","author":"B Hinkes","year":"2006","unstructured":"Hinkes B, Wiggins RC, Gbadegesin R, Vlangos CN, Seelow D, Nurnberg G, Garg P, Verma R, Chaib H, Hoskins BE, Ashraf S, Becker C, Hennies HC, Meera Goyal M, Wharram BL, Schachter AD, Mudumana S, Drummond I, Kerjaschki D, Waldherr R, Dietrich A, Ozaltin F, Bakkaloglu A, Cleper R, Basel-Vanagaite L, Pohl M, Griebel M, Tsygin AN, Alper Soylu A, Muller D, Sorli CS, Bunney TD, Katan M, Liu J, Attanasio M, O\u2019Toole JF, Hasselbacher K, Mucha B, Otto EA, Airik R, Kispert A, Kelley GG, Smrcka AV, Gudermann T, Holzman LB, Nurnberg P, Hildebrandt F (2006) Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat Genet 38(12):1397\u20131405","journal-title":"Nat Genet"},{"key":"3459_CR30","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nm.1857","volume":"14","author":"C Faul","year":"2008","unstructured":"Faul C, Donnelly M, Merscher-Gomez S, Chang YH, Franz S, Delfgaauw J, Chang JM, Choi HY, Campbell KN, Kim K, Reiser J, Mundel P (2008) The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 14:931\u2013938","journal-title":"Nat Med"},{"issue":"4","key":"3459_CR31","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.ajpath.2011.06.033","volume":"179","author":"T Nijenhuis","year":"2011","unstructured":"Nijenhuis T, Sloan AJ, Hoenderop J, Flesche J, van Goor H, Kistler AD, Bakker M, Bindels R, de Boer RA, M\u00f6ller CC, Hamming I, Navis G, Wetzels J, Berden J, Reiser J, Faul C, van der Vlag J (2011) Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway. Am J Pathol 179(4):1719\u20131732","journal-title":"Am J Pathol"},{"key":"3459_CR32","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/ki.2011.195","volume":"80","author":"DS Gipson","year":"2011","unstructured":"Gipson DS, Trachtman H, Kaskel FJ, Greene TH, Radeva MK, Gassman JJ, Moxey-Mims MM, Hogg RJ, Watkins SL, Fine RN, Hogan SL, Middleton JP, Vehaskari VM, Flynn PA, Powell LM, Vento SM, McMahan JL, Siegel N, D\u2019Agati VD, Friedman AL (2011) Clinical trial of focal segmental glomerulosclerosis in children and young adults. Kidney Int 80:868\u2013878","journal-title":"Kidney Int"},{"key":"3459_CR33","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2215\/CJN.08330812","volume":"8","author":"RJ Hogg","year":"2013","unstructured":"Hogg RJ, Friedman A, Greene T, Radeva M, Budisavljevic MN, Gassman J, Gipson DS, Jefferson JA, John EG, Kaskel FJ, Moudgil A, Moxey-Mims M, Ortiz LA, Schelling JR, Schnaper W, Srivastava T, Trachtman H, Vehaskari VM, Wong C, Woronieki RP, Van Why SK, Zolotnitskaya A (2013) Renal function and proteinuria after successful immunosuppressive therapies in patients with FSGS. Clin J Am Soc Nephrol 8:211\u2013218","journal-title":"Clin J Am Soc Nephrol"},{"key":"3459_CR34","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2215\/CJN.06100612","volume":"8","author":"VD D\u2019Agati","year":"2013","unstructured":"D\u2019Agati VD, Alster JM, Jennette JC, Thomas DB, Pullman J, Savino DA, Cohen AH, Gipson DS, Gassman JJ, Radeva MK, Moxey-Mims MM, Friedman AL, Kaskel FJ, Trachtman H, Alpers CE, Fogo AB, Greene TH, Nast CC (2013) Association of histologic variants in FSGS clinical trial with presenting features and outcomes. Clin J Am Soc Nephrol 8:399\u2013406","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9950","key":"3459_CR35","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/S0140-6736(14)60541-9","volume":"384","author":"K Iijima","year":"2014","unstructured":"Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, Miura K, Aya K, Nakanishi K, Ohtomo Y, Takahashi S, Tanaka R, Kaito H, Nakamura H, Ishikura K, Ito S, Ohashi Y (2014) Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 384(9950):1273\u20131281","journal-title":"Lancet"},{"issue":"26","key":"3459_CR36","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1056\/NEJMc063706","volume":"356","author":"A Bagga","year":"2007","unstructured":"Bagga A, Sinha A, Moudgil A (2007) Rituximab in patients with steroid resistant nephrotic syndrome. N Engl J Med 356(26):2751\u20132752","journal-title":"N Engl J Med"},{"key":"3459_CR37","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1681\/ASN.2011080775","volume":"23","author":"A Magnasco","year":"2012","unstructured":"Magnasco A, Ravani P, Edefonti A, Murer L, Ghio L, Belingheri M, Benetti E, Murtas C, Messina G, Massella L, Porcellini MG, Montagna M, Regazzi M, Scolari F, Ghiggeri G (2012) Rituximab in children with resistant idiopathic nephrotic syndrome. J Am Soc Nephrol 23:1117\u20131124","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"3459_CR38","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00467-014-2765-z","volume":"29","author":"K Kamei","year":"2014","unstructured":"Kamei K, Okada M, Sato M, Fujimaru T, Ogura M, Nakayama M, Kaito H, Iijima K, Ito S (2014) Rituximab treatment combined with methylprednisolone pulse therapy and immunosuppressants for childhood steroid-resistant nephrotic syndrome. Pediatr Nephrol 29(7):1181\u20131187","journal-title":"Pediatr Nephrol"},{"key":"3459_CR39","doi-asserted-by":"publisher","first-page":"242","DOI":"10.5414\/CNP60242","volume":"60","author":"MJ Kemper","year":"2003","unstructured":"Kemper MJ, Meyer-Jark T, Lilova M, Muller-Wiefel DE (2003) Combined T- and B-cell activation in childhood steroid-sensitive nephrotic syndrome. Clin Nephrol 60:242\u2013247","journal-title":"Clin Nephrol"},{"key":"3459_CR40","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00262-011-1168-2","volume":"61","author":"D Stroopinsky","year":"2012","unstructured":"Stroopinsky D, Katz T, Rowe JM, Melamed D, Avivi I (2012) Rituximab-induced direct inhibition of T-cell activation. Cancer Immunol Immunother 61:1233\u20131241","journal-title":"Cancer Immunol Immunother"},{"key":"3459_CR41","doi-asserted-by":"publisher","first-page":"85ra46","DOI":"10.1126\/scitranslmed.3002231","volume":"3","author":"A Fornoni","year":"2011","unstructured":"Fornoni A, Sageshima J, Wei C, Merscher-Gomez S, Aguillon-Prada R, Jauregui AN, Li J, Mattiazzi A, Ciancio G, Chen L, Zilleruelo G, Abitbol C, Chandar J, Seeherunvong W, Ricordi C, Ikehata M, Rastaldi MP, Reiser J, Burke GW 3rd (2011) Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med 3:85ra46","journal-title":"Sci Transl Med"},{"key":"3459_CR42","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.trsl.2008.04.001","volume":"151","author":"VJ Savin","year":"2008","unstructured":"Savin VJ, McCarthy ET, Sharma R, Charba D, Sharma M (2008) Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity. Transl Res 151:288\u2013292","journal-title":"Transl Res"},{"key":"3459_CR43","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1093\/ndt\/gfp278","volume":"24","author":"E De Smet","year":"2009","unstructured":"De Smet E, Rioux JP, Ammann H, Deziel C, Querin S (2009) FSGS permeability factor-associated nephrotic syndrome: remission after oral galactose therapy. Nephrol Dial Transplant 24:2938\u20132940","journal-title":"Nephrol Dial Transplant"},{"key":"3459_CR44","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1007\/s00467-013-2539-z","volume":"28","author":"K Sgambat","year":"2013","unstructured":"Sgambat K, Banks M, Moudgil A (2013) Effect of galactose on glomerular permeability and proteinuria in steroid-resistant nephrotic syndrome. Pediatr Nephrol 28:2131\u20132135","journal-title":"Pediatr Nephrol"},{"key":"3459_CR45","doi-asserted-by":"publisher","unstructured":"Trachtman H, Vento S, Gipson D, Wickman L, Gassman J, Joy M, Savin V, Somers M, Pinsk M, Greene T (2011). Novel Therapies for resistant focal segmental glomerulosclerosis (FONT2) phase II clinical trial: study design. BMC Nephrol 12:8. doi: 10.1186\/1471-2369-12-8","DOI":"10.1186\/1471-2369-12-8"},{"key":"3459_CR46","first-page":"53","volume":"24","author":"A Ortiz","year":"1995","unstructured":"Ortiz A, Bustos C, Alonso J, Alcazar R, Lopez-Armada MJ, Plaza JJ, Gonzalez E, Egido J (1995) Involvement of tumor necrosis factor-alpha in the pathogenesis of experimental and human glomerulonephritis. Adv Nephrol Necker Hosp 24:53\u201377","journal-title":"Adv Nephrol Necker Hosp"},{"issue":"1","key":"3459_CR47","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1053\/j.ajkd.2009.08.019","volume":"55","author":"MS Joy","year":"2010","unstructured":"Joy MS, Gipson DS, Powell L, MacHardy J, Jennette JC, Vento S, Pan C, Savin V, Eddy A, Fogo AB, Kopp JB, Cattran D, Trachtman H (2010) Phase 1 Trial of Adalimumab in Focal Segmental Glomerulosclerosis (FSGS): Report of the FONT (Novel Therapies for Resistant FSGS) Study Group. Am J Kidney Dis 55(1):55\u201360","journal-title":"Am J Kidney Dis"},{"issue":"25","key":"3459_CR48","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1056\/NEJMoa1304572","volume":"369","author":"C Chih-Chuan Yu","year":"2013","unstructured":"Chih-Chuan Yu C, Fornoni A, Weins A, Hakroush S, Maiguel D, Sageshima J, Chen L, Ciancio G, Faridi MH, Behr D, Campbell KN, Chang J, Chen H, Oh J, Faul C, Arnaout MA, Fiorina P, Gupta V, Greka A, Burke GW, Mundel P (2013) Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med 369(25):2416\u20132423","journal-title":"N Engl J Med"},{"key":"3459_CR49","unstructured":"Benigni A, Gagliardini E, Remuzzi G (2014) Comment in Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med 370(13):1261\u20131263"},{"issue":"3","key":"3459_CR50","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00467-014-2957-6","volume":"30","author":"EH Garin","year":"2015","unstructured":"Garin EH, Reiser J, Cara-Fuentes G, Wei C, Matar D, Wang H, Alachkar N, Johnson RJ (2015) Case series: CTLA4\u2013IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis. Pediatr Nephrol 30(3):469\u2013477","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"3459_CR51","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1172\/JCI102437","volume":"30","author":"HL Barnett","year":"1951","unstructured":"Barnett HL, Forman CW, McNamara H, McCrory WW, Rapoport M, Michie AJ, Barbero G (1951) The effect of adrenocorticotrophic hormone on children with the nephrotic syndrome. II. Physiologic observations on discrete kidney functions and plasma volume. J Clin Invest 30(2):227\u2013235","journal-title":"J Clin Invest"},{"issue":"12","key":"3459_CR52","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.2215\/CJN.02840313","volume":"8","author":"J Hogan","year":"2013","unstructured":"Hogan J, Bomback AS, Mehta K, Canetta PA, Rao MK, Appel GB, Radhakrishnan J, Lafayette RA (2013) Treatment of idiopathic FSGS with adrenocorticotropic hormone gel. Clin J Am Soc Nephrol 8(12):2072\u20132081","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-016-3459-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-016-3459-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-016-3459-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T09:44:13Z","timestamp":1657532653000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-016-3459-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,26]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["3459"],"URL":"https:\/\/doi.org\/10.1007\/s00467-016-3459-5","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,26]]},"assertion":[{"value":"26 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Supported by NIH grant T32 DK007110.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Sources of funding"}}]}}